Abstract
BACKGROUND
Periodic limb movements in sleep (PLMS) is an uncommon sleep disorder in the paediatric population. Recently, an association between PLMS and attention deficit hyperactivity disorder (ADHD) in children was identified.
OBJECTIVE
To review the current literature and describe the common clinical presentations and pathophysiology related to both ADHD and PLMS.
METHODS
A comprehensive, electronic medical literature review was performed using search terms related to both PLMS and ADHD, with age limits applied to select for the paediatric population. A manual review of these articles was performed to identify other key reports relating to the topic.
RESULTS
The symptoms of PLMS in children are very similar to those of ADHD. Both disorders are related to dopamine production and metabolism, and both respond to dopaminergic therapy. The coexistence of ADHD and PLMS is reported to occur with some frequency. The potential for misdiagnosis of ADHD in a child with PLMS exists, given the similar clinical presentations. Recommendations regarding the identification of children undergoing evaluation for possible ADHD who may benefit from polysomnography are suggested.
CONCLUSIONS
Both ADHD and PLMS may present with daytime symptoms of hyperactivity, impulsivity, inattentiveness and decreased school performance. Physicians should consider PLMS in the differential diagnosis of a child with ADHD symptoms.
Keywords: Attention deficit hyperactivity disorder, Children, Periodic limb movement disorder, Restless legs syndrome, Sleep disorders
Abstract
HISTORIQUE
Les mouvements involontaires des membres pendant le sommeil (MIMS) sont un trouble du sommeil peu courant au sein de la population pédiatrique. Récemment, on a remarqué une association entre les MIMS et le trouble de l’attention avec hyperactivité (TDAH) chez les enfants.
OBJECTIF
Analyser les publications à jour et décrire les présentations cliniques courantes et la physiopathologie reliées tant au TDAH qu’aux MIMS.
MÉTHODOLOGIE
Une analyse électronique complète des publications médicales a été exécutée à l’aide de termes de recherche reliés à la fois aux MIMS et au TDAH, des limites d’âge étant appliquées pour sélectionner la population pédiatrique. Un examen manuel de ces articles a permis de repérer d’autres comptes rendus importants sur le sujet.
RÉSULTATS
Les symptômes de MIMS chez les enfants sont très semblables à ceux du TDAH. Ces deux troubles sont reliés à la production et au métabolisme de la dopamine, et tous deux réagissent à un traitement dopaminergique. Le TDAH et les MIMS coexistent à une certaine fréquence. Il existe un potentiel de faux diagnostic de TDAH chez un enfant atteint de MIMS, en raison des présentations cliniques similaires. Des recommandations sont suggérées à l’égard du dépistage des enfants subissant une évaluation en vue d’un TDAH et qui pourraient tirer profit d’une polysomnographie.
CONCLUSIONS
Tant le TDAH que les MIMS peuvent s’associer à des symptômes diurnes d’hyperactivité, d’impulsivité, d'inattention et à de moins bons résultats scolaires. Les médecins devraient envisager la possibilité de MIMS dans leur diagnostic différentiel d’un enfant présentant des symptômes de TDAH.
ATTENTION DEFICIT HYPERACTIVITY DISORDER
Attention deficit hyperactivity disorder (ADHD) affects 5% to 10% of school-aged children in North America and is the most commonly diagnosed behavioural disorder in the world (1–4). Children with ADHD have 150% more primary care visits and roughly 10 times more outpatient mental health visits per year than do children without ADHD (5). It is estimated that two-and-a-half billion dollars per year are spent on the diagnosis and treatment of ADHD in the United States (6). When children go undiagnosed, the costs to the health care system, the educational system, their families and the children themselves have the potential to be immense and long-standing. Children with ADHD have been shown to have a higher school dropout rate, achieve a lower educational level than average, have lower paying jobs and be at an increased risk of living in poverty (6–8). Added to this are the frustration and cost of a potential misdiagnosis. The family physician has an important and critical role in providing a prompt and accurate diagnosis for a child with ADHD.
Many disorders have symptoms that overlap with those of ADHD. Historically, the Diagnostic and Statistical Manual of Mental Disorders, Third Edition (9) diagnostic criteria for ADHD included sleep disorders among the differential diagnoses, which needed to be excluded before a diagnosis of ADHD could be made. Despite mounting evidence of the connection between sleep disorders and ADHD, the more recent Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (10) does not include sleep disorders as a cause for ADHD-related symptoms. Nevertheless, the following sleep disorders have been shown to be associated with symptoms of ADHD: sleep-related breathing disorders, such as sleep apnea and upper airway resistance syndrome; restless legs syndrome (RLS); periodic limb movements in sleep (PLMS); and narcolepsy (11–20). The present review focuses on the relationship among RLS, PLMS and ADHD.
RLS AND PLMS
RLS is a clinical disorder that is commonly associated with ADHD (16). RLS has been loosely defined as an uncomfortable sensation in the legs that is relieved by leg movements, and tends to be worse at night and when sitting or lying. There are no standardized diagnostic criteria for the diagnosis of RLS and, consequently, there are no studies that report the incidence of RLS in children (21). However, 80% of patients with RLS also have characteristic leg movements during sleep that meet the diagnostic criteria for PLMS (22). PLMS is objectively defined as the presence of repetitive movements, typically flexions, of the toes, feet, legs, thighs and, sometimes, arms that last 0.5 s to 5 s and occur at 5 s to 90 s intervals during sleep. These movements are identified and quantitated with an anterior tibialis electromyogram during overnight polysomnography (PSG) testing (sleep study). For the purposes of clarity throughout the present review, the authors use the term PLMS to refer to children with repetitive limb movements that meet the objective diagnostic criteria as outlined above, occurring at least five times or more per hour (8).
The prevalence of PLMS in children diagnosed with ADHD is estimated to be as high as 26% compared with a prevalence of only 1.2% in paediatric populations at risk for sleep disorders (15,16,23). The increased rate of PLMS in children with ADHD may be due to the considerable overlap in symptoms of the two disorders. In children, both disorders produce daytime symptoms of hyperactivity, inattentiveness, distractibility, motor restlessness, moodiness, emotional sensitivity and decreased academic performance (16,17,23–27). These commonalities suggest that there may be a subset of children diagnosed with ADHD who actually have unidentified PLMS rather than a behavioural disorder. Alternatively, the commonalities of symptoms may prove to be a consequence of a shared pathophysiology of the two disorders, leading to their coexistence.
PATHOPHYSIOLOGY OF ADHD AND PLMS
The etiology of ADHD is most certainly complex, and various potential pathways have been hypothesized. Despite great interest and research efforts, the etiology of ADHD remains unknown. Current treatments for ADHD –methylphenidate and dextroamphetamine sulfate – increase dopaminergic activity in the central nervous system (28–30). Attention, therefore, is now being focused on the potential relationship between dopamine deficiency and the symptoms of ADHD. Konofal et al (31) have contributed to this hypothesis: they reported that low serum ferritin levels were commonly identified in a significant number of children with ADHD and PLMS. They noted that serum ferritin levels correlated with the severity of ADHD symptoms (31). Iron is required for the rate-limiting step in the conversion of tyrosine to levodopa, an important precursor to dopamine (Figure 1). Decreased iron availability decreases the production of levodopa and, therefore, of dopamine.
A low serum ferritin level is not identified in all children with ADHD and PLMS, which raises the possibility of additional or alternative problems related to iron metabolism or transport. Children with normal levels of ferritin and transferrin in the serum can have low levels of ferritin and high levels of transferrin in the cerebrospinal fluid, indicating a decreased availability of iron to the brain for essential functions, such as the production of dopamine (32).
Iron deficiency in the brain results in decreased dopamine production, contributing to motor restlessness, particularly in the form of PLMS. The limb movements experienced by these patients during sleep produce sleep fragmentation and can lead to sleep deprivation. Sleep deprivation manifests itself clinically through daytime symptoms of hyperactivity, inattentiveness, distractibility, motor restlessness, moodiness, emotional sensitivity and decreased academic performance, all symptoms supporting a diagnosis of ADHD (11–14,16,17).
Both PLMS and ADHD have been shown to be related to dopamine production and metabolism (33). Walters et al (33) conducted a small, nonrandomized, nonblinded trial to study the effect of dopaminergic therapy in patients with ADHD and PLMS. Their study included eight children: five children had diagnoses of both PLMS and ADHD, two children had only PLMS and one child had RLS. The children were given trials of levodopa and pergolide (dopaminergic agents), and then were retested six months later to determine whether they still met the diagnostic criteria for their disorders. Of the seven children who completed the trial, Walters et al (33) reported that treatment with dopaminergic agents reduced the number of periodic limb movements per hour of sleep (P=0.018) and improved daytime symptoms in all participants (P<0.05). Daytime symptoms were so dramatically improved that three of the children no longer met the criteria for a diagnosis of ADHD (33). Follow-up three years later revealed that five of the seven children had remained on dopaminergic therapy and continued to show “good response”. As a result of this study, Walters et al (33) postulated that “the improvement in ADHD may be the result of the amelioration of RLS/PLMS and its associated sleep disturbance. Alternatively, ADHD and RLS/PLMS may share a common dopaminergic deficit”. This study is the foundation for potential larger, randomized, double-blind studies, none of which have been undertaken to date.
IDENTIFICATION OF PLMS IN CHILDREN
Given the similar presentations of ADHD and PLMS, physicians should be familiar with the relationship between them and the potential for misdiagnosis. Chervin and Hedger (22) recently published a short, validated screening questionnaire that can be quickly and easily incorporated into the workup of a child in whom a diagnosis of ADHD is suspected (34) (Table 1). Positive responses to these questions may help to identify patients with 79% sensitivity and 56% specificity. The positive predictive value of this screening tool is 0.38 and the negative predictive value is 0.89. While not an ideal predictive tool, this questionnaire can be easily and quickly implemented to identify children for whom a referral for further investigation for sleep disorders may be indicated.
TABLE 1.
Does your child describe restlessness of the legs when in bed? |
Does your child have ‘growing pains’ that are worst in bed? |
At night, does your child usually get out of bed (for any reason)? |
Does your child wake up more than twice a night on average? |
Does your child wake up feeling unrefreshed in the morning? |
Does your child wake up with headaches in the morning? |
Data from reference 22
PSG is the current gold standard diagnostic test for the diagnosis of PLMS and is available in many paediatric tertiary centres. Complete PSG includes monitoring of the following physiological parameters: electroencephalography for sleep architecture and efficiency, electrooculography to record eye movements, electrocardiography, measures of oral and nasal airflow, ventilation, leg and respiratory accessory muscle electromyography, and pulse oximetry. A PSG technician continuously observes the child during sleep to provide behavioural data. The study itself is noninvasive and performed by staff trained in dealing with the special needs and fears of children. A detailed interpretation and report is forwarded to the referring physician with recommendations for follow-up or treatment, when appropriate. When evidence of PLMS is present on PSG, specific investigation and treatment recommendations are often included with the report.
SUMMARY
Sleep disorders such as PLMS should be considered in the differential diagnosis of a child in whom a diagnosis of ADHD is suspected. Simple screening questions can help identify children who may benefit from PSG study and a referral to a paediatric sleep specialist.
Children with PLMS who are symptomatic but have no identifiable cause of their symptoms should be given a trial of dopaminergic medication. A trial of iron supplementation may also be considered, either before treatment with dopaminergic agents or as adjunctive therapy. Dopaminergic therapies reported for the treatment of PLMS in children include levodopa/carbidopa (75/300 mg to 150/600 mg daily) and pergolide (0.4 mg to 1 mg daily), with a typical dosing of four times daily (30). Collaboration with the sleep specialist and a follow-up PSG study is encouraged to confirm treatment effects.
REFERENCES
- 1.Guevara JP, Stein MT. Attention deficit hyperactivity disorder. West J Med. 2001;175:189–93. doi: 10.1136/ewjm.175.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Wolraich ML, Hannah JN, Pinnock TY, Baumgaertel A, Brown J. Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample. J Am Acad Child Adolesc Psychiatry. 1996;35:319–24. doi: 10.1097/00004583-199603000-00013. [DOI] [PubMed] [Google Scholar]
- 3.LeFever GB, Dawson KV, Morrow AL. The extent of drug therapy for attention deficit-hyperactivity disorder among children in public schools. Am J Public Health. 1999;89:1359–64. doi: 10.2105/ajph.89.9.1359. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Baumgaertel A, Wolraich ML, Dietrich M. Comparison of diagnostic criteria for attention deficit disorders in a German elementary school sample. J Am Acad Child Adolesc Psychiatry. 1995;34:629–38. doi: 10.1097/00004583-199505000-00015. [DOI] [PubMed] [Google Scholar]
- 5.Guevara J, Lozano P, Wickizer T, Mell L, Gephart H. Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108:71–8. doi: 10.1542/peds.108.1.71. [DOI] [PubMed] [Google Scholar]
- 6.Chan E, Zhan C, Homer CJ. Health care use and costs for children with attention-deficit/hyperactivity disorder: National estimates from the medical expenditure panel survey. Arch Pediatr Adolesc Med. 2002;156:504–11. doi: 10.1001/archpedi.156.5.504. [DOI] [PubMed] [Google Scholar]
- 7.American Sleep Disorders Association. International Classification of Sleep Disorders, Revised: Diagnostic and Coding Manual. Rochester: American Sleep Disorders Association; 1997. pp. 65–8. [Google Scholar]
- 8.Fischer M, Barkley RA, Fletcher KE, Smallish L. The adolescent outcome of hyperactive children: Predictors of psychiatric, academic, social, and emotional adjustment. J Am Acad Child Adolesc Psychiatry. 1993;32:324–32. doi: 10.1097/00004583-199303000-00013. [DOI] [PubMed] [Google Scholar]
- 9.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 3. Washington: American Psychiatric Association; 1980. [Google Scholar]
- 10.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4. Washington: American Psychiatric Association; 1994. [Google Scholar]
- 11.Chervin RD, Dillon JE, Bassetti C, Ganoczy DA, Pituch KJ. Symptoms of sleep disorders, inattention, and hyperactivity in children. Sleep. 1997;20:1185–92. doi: 10.1093/sleep/20.12.1185. [DOI] [PubMed] [Google Scholar]
- 12.Guilleminault C, Korobkin R, Winkle R. A review of 50 children with obstructive sleep apnea syndrome. Lung. 1981;159:275–87. doi: 10.1007/BF02713925. [DOI] [PubMed] [Google Scholar]
- 13.Guilleminault C, Winkle R, Korobkin R, Simmons B. Children and nocturnal snoring: Evaluation of the effects of sleep related respiratory resistive load and daytime functioning. Eur J Pediatr. 1982;139:165–71. doi: 10.1007/BF01377349. [DOI] [PubMed] [Google Scholar]
- 14.Ali NJ, Pitson DJ, Stradling JR. Snoring, sleep disturbance, and behaviour in 4–5 year olds. Arch Dis Child. 1993;68:360–6. doi: 10.1136/adc.68.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Kirk VG, Bohn S. Periodic limb movements in children: Prevalence in a referred population. Sleep. 2004;27:313–5. doi: 10.1093/sleep/27.2.313. [DOI] [PubMed] [Google Scholar]
- 16.Picchietti DL, England SJ, Walters AS, Willis K, Verrico T. Periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. J Child Neurol. 1998;13:588–94. doi: 10.1177/088307389801301202. [DOI] [PubMed] [Google Scholar]
- 17.Picchietti DL, Walters AS. Restless legs syndrome and periodic limb movement disorder in children and adolescents: Comorbidity with attention-deficit hyperactivity disorder. Child Adolesc Psychiatr Clin North Am. 1996;5:729–40. [Google Scholar]
- 18.Chervin RD, Archbold KH. Hyperactivity and polysomnographic findings in children evaluated for sleep-disordered breathing. Sleep. 2001;24:313–20. doi: 10.1093/sleep/24.3.313. [DOI] [PubMed] [Google Scholar]
- 19.Konofal E, Lecendreux M, Bouvard MP, Mouren-Simeoni MC. High levels of nocturnal activity in children with attention-deficit hyperactivity disorder: A video analysis. Psychiatry Clin Neurosci. 2001;55:97–103. doi: 10.1046/j.1440-1819.2001.00808.x. [DOI] [PubMed] [Google Scholar]
- 20.Kaplan BJ, McNicol J, Conte RA, Moghadam HK. Sleep disturbance in preschool-aged hyperactive and nonhyperactive children. Pediatrics. 1987;80:839–44. [PubMed] [Google Scholar]
- 21.Walters AS, Hickey K, Maltzman J, et al. A questionnaire study of 138 patients with restless legs syndrome: The ‘Night-Walkers’ survey. Neurology. 1996;46:92–5. doi: 10.1212/wnl.46.1.92. [DOI] [PubMed] [Google Scholar]
- 22.Chervin RD, Hedger KM. Clinical prediction of periodic leg movements during sleep in children. Sleep Med. 2001;2:501–10. doi: 10.1016/s1389-9457(01)00069-7. [DOI] [PubMed] [Google Scholar]
- 23.Picchietti DL, Underwood DJ, Farris WA, et al. Further studies on periodic limb movement disorder and restless legs syndrome in children with attention-deficit hyperactivity disorder. Mov Disord. 1999;14:1000–7. doi: 10.1002/1531-8257(199911)14:6<1000::aid-mds1014>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
- 24.Pilcher JJ, Huffcutt AI. Effects of sleep deprivation on performance: A meta-analysis. Sleep. 1996;19:318–26. doi: 10.1093/sleep/19.4.318. [DOI] [PubMed] [Google Scholar]
- 25.Dahl RE, Pelham WE, Wierson M. The role of sleep disturbances in attention deficit disorder symptoms: A case study. J Pediatr Psychol. 1991;16:229–39. doi: 10.1093/jpepsy/16.2.229. [DOI] [PubMed] [Google Scholar]
- 26.Bergman RL. Treatment of childhood insomnia diagnosed as “hyperactivity”. J Behav Ther Exp Psychiatry. 1976;7:199–201. [Google Scholar]
- 27.Mindell JA, Vari CA. Sleep problems and daytime behavior problems in young children: Is there a relationship? Sleep Res. 1992;21:234. (Abst) [Google Scholar]
- 28.Klassen A, Miller A, Raina P, Lee SK, Olsen L. Attention-deficit hyperactivity disorder in children and youth: A quantitative systematic review of the efficacy of different management strategies. Can J Psychiatry. 1999;44:1007–16. doi: 10.1177/070674379904401007. [DOI] [PubMed] [Google Scholar]
- 29.Solanto MV. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res. 1998;94:127–52. doi: 10.1016/s0166-4328(97)00175-7. [DOI] [PubMed] [Google Scholar]
- 30.Nieoullon A. Dopamine and the regulation of cognition and attention. Prog Neurobiol. 2002;67:53–83. doi: 10.1016/s0301-0082(02)00011-4. [DOI] [PubMed] [Google Scholar]
- 31.Konofal E, Lecendreux M, Arnulf I, Mouren MC. Restless legs syndrome and serum ferritin levels in ADHD children. Sleep. 2003;26:A136–7. [Google Scholar]
- 32.Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54:1698–700. doi: 10.1212/wnl.54.8.1698. [DOI] [PubMed] [Google Scholar]
- 33.Walters AS, Mandelbaum DE, Lewin DS, Kugler S, England SJ, Miller M. Dopaminergic therapy in children with restless legs/periodic limb movements in sleep and ADHD. Dopaminergic Therapy Study Group. Pediatr Neurol. 2000;22:182–6. doi: 10.1016/s0887-8994(99)00152-6. [DOI] [PubMed] [Google Scholar]
- 34.Collado-Seidel V, Kohnen R, Samtleben W, Hillebrand GF, Oertel WH, Trenkwalder C. Clinical and biochemical findings in uremic patients with and without restless legs syndrome. Am J Kidney Dis. 1998;31:324–8. doi: 10.1053/ajkd.1998.v31.pm9469505. [DOI] [PubMed] [Google Scholar]